A Study to Test Whether Spesolimab Helps People With a Skin Disease Called Hidradenitis Suppurativa
Clinical trial NCT04762277 · COMPLETED
Trial details
- NCT number
- NCT04762277
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-06
- Primary completion
- 2022-01-19
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.